Who We Aim to Help

Bioptamers is committed to developing personalized precision therapies for patients with the greatest unmet medical need. Our initial focus is on aggressive, rapidly progressing, and highly invasive cancers for which current standard-of-care therapies have failed, are no longer effective, or are not available. Our lead programs are currently at the in vivo proof-of-concept stage, representing an important milestone toward developing next-generation personalized cancer therapies.